Comparing BrightSpring Health Services (NASDAQ:BTSG) and Progyny (NASDAQ:PGNY)

BrightSpring Health Services (NASDAQ:BTSG) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

Valuation and Earnings

This table compares BrightSpring Health Services and Progyny”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91 billion	1.01	$190.67 million	$1.41	46.99
Progyny	$1.29 billion	1.59	$58.52 million	$0.77	33.87

BrightSpring Health Services has higher revenue and earnings than Progyny. Progyny is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

BrightSpring Health Services has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for BrightSpring Health Services and Progyny, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0	0	16	2	3.11
Progyny	0	3	11	0	2.79

BrightSpring Health Services presently has a consensus target price of $59.60, indicating a potential downside of 10.04%. Progyny has a consensus target price of $29.67, indicating a potential upside of 13.75%. Given Progyny’s higher probable upside, analysts plainly believe Progyny is more favorable than BrightSpring Health Services.

Profitability

This table compares BrightSpring Health Services and Progyny’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Progyny	5.23%	13.34%	9.03%

Insider & Institutional Ownership

94.9% of Progyny shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Comparatively, 9.9% of Progyny shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats Progyny on 9 of the 15 factors compared between the two stocks.

About BrightSpring Health Services

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.